Stay updated on Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.

Latest updates to the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page
- Check6 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe record history shows new entries for Active, not recruiting status, Study Status, Recruitment Status, and Contacts/Locations, with a revision noted as v3.4.2 on 2026-02-05.SummaryDifference2%

- Check41 days agoChange DetectedAdded a government funding notice banner and updated the page to Revision: v3.4.1, replacing the previous v3.4.0 tag. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check48 days agoChange DetectedThe Record History page now includes a Show glossary option and uses green highlights for additions and red highlights for deletions. It also shows a new revision note (Revision: v3.4.0) and minor text/casing tweaks such as No FEAR Act Data.SummaryDifference1%

- Check62 days agoChange DetectedThe record history shows a new revision tag (v3.3.4) replacing the previous one (v3.3.3). This appears to be a backend/format update with no visible changes to study information.SummaryDifference0.1%

- Check84 days agoChange DetectedThe history shows a new revision entry (Revision: v3.3.3) and removal of HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cadonilimab & Regorafenib Combo in Hepatocellular Carcinoma Clinical Trial page.